Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Canada Approves Second Generic Version Of Ozempic

The ⁠Canadian health regulator ⁠said on ⁠Friday that ‌it had approved Canada-based Apotex's generic ‌version of semaglutide, making ‌it ‌the second copycat ⁠version of...

Constipation Linked to Greater Weight Loss on Semaglutide

Patients on semaglutide who experienced constipation had greater weight loss than those without constipation, and genes could be at play.

GLP-1 Semaglutide Promising for Alcohol Use Disorder

Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol use disorder.

Diabetes Before Pregnancy May Affect Kids’ Brain Development

Children of mothers with pregestational diabetes may have an increased risk of developing subsequent neuropsychiatric disorders.

GLP-1 Drugs May Modestly Raise Optic Neuropathy Risk in T2D

GLP-1 therapy is linked to a modestly increased risk for nonarteritic anterior ischemic optic neuropathy compared with SGLT2 inhibitors in veterans with type 2 diabetes.

Capecitabine Extends PFS in Oesophagogastric Cancer

Maintenance therapy with capecitabine prolongs progression-free survival in patients with advanced oesophagogastric adenocarcinoma after first-line chemotherapy.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Todays Updates

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Study Finds Microplastics Near Tumors; Experts Doubt Results

Using LDIR, O PTIR, Py GC/MS, and SEM, researchers quantified MNPs in 191 brain samples, but experts question the unusually high particle masses and urge methodological validation.

Latest News

The ⁠Canadian health regulator ⁠said on ⁠Friday that ‌it had approved Canada-based Apotex's generic ‌version of semaglutide, making ‌it ‌the second copycat ⁠version of...

Patients on semaglutide who experienced constipation had greater weight loss than those without constipation, and genes could be at play.

Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol use disorder.

Children of mothers with pregestational diabetes may have an increased risk of developing subsequent neuropsychiatric disorders.

GLP-1 therapy is linked to a modestly increased risk for nonarteritic anterior ischemic optic neuropathy compared with SGLT2 inhibitors in veterans with type 2 diabetes.

Maintenance therapy with capecitabine prolongs progression-free survival in patients with advanced oesophagogastric adenocarcinoma after first-line chemotherapy.

News All Time

FDA Proposes End to Mass GLP-1 Compounding

The agency appears to leave a loophole for patient-specific formulations.

Food Insecurity and Poverty May Raise MASLD Risk in US

People who do not have enough food to eat or who live below the poverty level are more likely to develop MASLD, and this risk is higher in non-Hispanic White individuals.

‘Cyborg’ Islet Cells and Potential New Diabetes Therapies

Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of previously unseen data on islet cell function.

Canada Approves First Generic Version Of Ozempic Amid Rising GLP-1 Competition

Health Canada has approved the first generic version of Danish drugmaker Novo Nordisk's blockbuster diabetes drug Ozempic made ⁠by Indian drugmaker Dr Reddy's Laboratories,...

Autusm Advisory Board Focuses on 'profound Autism,' Improved Medical Care

A U.S. advisory committee appointed by Health Secretary Robert F. Kennedy Jr. recommended on Tuesday that the government adopt the term "profound autism” for those with the...

Migraine Med Shows Weight-Loss Benefit

New data show early and sustained weight loss with atogepant, raising the possibility of metabolic benefits beyond migraine prevention.

HIV Patients in Senegal Skip Treatment Amid LGBTQ Arrests

Fewer patients are visiting some HIV treatment centres in Senegal amid a wave of arrests targeting LGBTQ people, threatening the country's fight against the virus.

Germany to Impose Levy on Sugary Drinks From 2028

Germany plans to impose a levy on sugary drinks under a healthcare reform package that aims to rein in rising rates of ⁠obesity and ease pressure on the health system.

Sleep Disorders Very Common in Patients With Osteoarthritis

While pain is recognized as a likely contributor to poor sleep, the relationship may be bidirectional, with sleep problems also contributing to osteoarthritis symptoms.

Brolucizumab Beats Laser Treatment in Diabetic Retinopathy

Intravitreal brolucizumab is superior to panretinal laser photocoagulation in preserving visual acuity for patients with proliferative diabetic retinopathy, clinical trial data show.

Bariatric Surgery Adapts to the GLP-1 Era

As GLP-1 use increases and bariatric surgery rates decline, practices are pivoting to comprehensive obesity care that integrates medical and surgical approaches.

Boehringer-Zealand Drug Leads to 16.6% Weight Loss in Late-stage Trial

Boehringer Ingelheim said on Tuesday its experimental obesity drug led to average weight loss of up to 16.6% in ⁠a late-stage trial, as the unlisted German drugmaker seeks...

Mobile App for Hand Osteoarthritis Improves Pain, Function

Though currently available only in Norwegian, the researchers are expanding the app to more languages, including English.

Low Obesity-Related QOL Motivates Kids Weight Management

Families may be more motivated to participate in a pediatric weight management program when children and adolescents experience lower obesity-related quality of life.

OA, Knee Replacement Risk Highest With Sarcopenic Obesity

The findings suggest that resistance training is an important adjunct to other exercise for patients with knee osteoarthritis.

Women With Acromegaly Face Greater Disease Burden Than Men

Women with acromegaly experience a significantly higher disease burden and poorer physical and mental quality of life than men.

Recommended News For You

The biology of cancer as well as potential treatment options are examined by experts.

Scientists call into question safety of potential new anticancer treatment

When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?

In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.

Sickle Cell Disease Drug Pulled From Global Markets

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals

Recommended Articles For You

What Is A High MCV Level? Causes, Symptoms, And Treatment Options 

The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects  

The Latest Research on Wiskott Aldrich Syndrome  

From Bruises to Blood Clots: Everything You Need to Know about Hematoma  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Unlocking the secrets of the fibrotic fortress that surrounds and protects pancreatic cancer

2.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

3.

Increased detection of adenomas may reduce colon cancer risk after colonoscopy in FIT-based screening.

4.

According to a study, breast cancer cells work together to physically breach barriers and proliferate.

5.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

1.

Exploring Innovative Solutions for Infantile Hemangioma Treatment

2.

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics

3.

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy

4.

Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments

5.

LncRNAs in Cancer: Shaping Tumor Progression & Paving New Paths for Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XVI

2.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

3.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

4.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

5.

Navigating the Complexities of Ph Negative ALL - Part X

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot